High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

NCT01976195 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No eligible patient was enrolled.

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Dexamethasone
DRUG: Thalidomide

Sponsor

Shandong University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]